Journal article
Adjustable Maintenance Dosing with Budesonide/Formoterol Reduces Asthma Exacerbations Compared with Traditional Fixed Dosing: A Five‐Month Multicentre Canadian Study
Abstract
BACKGROUND: Adjustable maintenance dosing with budesonide/formoterol in a single inhaler (Symbicort, AstraZeneca, Lund, Sweden) may provide a convenient means of maintaining asthma control with the minimum effective medication level.
OBJECTIVES: To compare adjustable and fixed maintenance dosing regimens of budesonide/formoterol in asthma.
Authors
FitzGerlad JM; Sears MR; Boulet L-P; Becker AB; McIvor AR; Ernst P; Smiljanic-Georgijev NM; Lee JS
Journal
Canadian Respiratory Journal, Vol. 10, No. 8, pp. 427–434
Publisher
Wiley
Publication Date
January 2003
DOI
10.1155/2003/298039
ISSN
1198-2241